1-((5-Iodonaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride, 98%, 10mg

2-Bromo-5-methoxybenzotrifluoride, 98.0%, 5g

Silanol terminated polydimethylsiloxane cSt 90,000-150,000, 100g

N-Hydroxysuccinimide, min. 99%, for synthesis, 25 g, glass packaging

DMT-2'-O-methyl-rG(Ib) Phosphoramidite>98.0%(HPLC)250mg

2-piperazin-1-yl-1,3-benzothiazole hydrochloride, 100mg

3-chloro-4-(3,5-dimethyl-1-piperidinyl)aniline, 95.0%, 5g

4-[2-(Dimethylamino)ethoxy]benzylamine, 97.0%, 25g

2-(4-CHLOROPHENYL)-2-PHENYLETHYLAMINE HCL, 95.0%, 250mg

Labels Tough Spots on the roll round, yellow, 12.7 mm, Gesch. for, 1.5/2 ml vials, 1 Roll

5-Fluoro-2-nitrobenzonitrile, 97.0%, 100g

2-(4-Amino-phenoxy)-acetamide, 500mg

6-Bromo-8-chloroimidazo[1,2-a]pyridine, 95.0%, 1g